IBBQ ETF (Invesco Nasdaq Biotechnology ETF) is managed by Invesco (US) with $75.6M in net assets. IBBQ expense ratio is 0.19%, holding 261 positions across sectors including Health Care, Unknown, Financials. Inception date: 2021-06-11.

IBBQ performance shows a YTD return of 15.17%. The 1-year return is 55.91% and the 5-year return is 5.69%. IBBQ dividend yield stands at 0.79%, paid quarterly.

IBBQ top holdings include Nvaesrtex Pharmaceuticals Inc (7.4%), Gilead Sciences Inc (7.3%), Amgen Inc. (7.1%), Regeneron Pharmaceuticals, Inc. (5.9%), Alnylam Pharmace (3.1%). View all IBBQ holdings, sector breakdown, or dividend history.

IBBQ can be compared against other funds using the overlap calculator or side-by-side comparison tool. IBBQ alternatives are available via the screener, along with tax-loss harvesting opportunities.